Patient-Reported Outcomes as Primary End Points in Clinical Trials of Inflammatory Bowel Disease Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet Clinical Gastroenterology and Hepatology Volume 12, Issue 8, Pages 1246-1256.e6 (August 2014) DOI: 10.1016/j.cgh.2014.02.016 Copyright © 2014 AGA Institute Terms and Conditions
Figure 1 FDA guidance for developing PROs.24 Clinical Gastroenterology and Hepatology 2014 12, 1246-1256.e6DOI: (10.1016/j.cgh.2014.02.016) Copyright © 2014 AGA Institute Terms and Conditions